Adenovirus-mediated atrial natriuretic protein expression in the lung protects rats from hypoxia-induced pulmonary hypertension.
Endogenous as well as exogenous atrial natriuretic peptide (ANP) attenuates the development of chronic hypoxic pulmonary hypertension (CHPH) in rats. We built a recombinant adenovirus type 5 containing ANP cDNA under the control of the Rous sarcoma virus long terminal repeat (Ad.ANP). The efficiency of this vector in delivering the ANP gene was first examined in rat primary cultures of pulmonary vessel smooth muscle cells (SMCs) in comparison with Ad.beta GAL. Conditioned medium collected from Ad.ANP-infected cells (1000 TCID(50)/cell) contained 5 x 10(9) M immunoreactive ANP and elicited relaxation of isolated rat pulmonary arteries preconstricted with phenylepinephrine. To examine the effects of adenovirus-mediated ANP expression in the CHPH rat lung, Ad.ANP or Ad.beta GAL was administered via the tracheal route. Immunoreactive ANP was detected in bronchoalveolar fluid as early as 4 days and until 10-17 days after Ad.ANP administration (5 x 10(8) TCID(50)). Lung ANP immunostaining was mainly localized in bronchial and alveolar epithelial cells. As compared with Ad.beta GAL-treated controls, rats given Ad.ANP (5 x 10(8) TCID(50)) on the day before a 2-week exposure to hypoxia (10% O(2)) had lower values for pulmonary artery pressure (32.1 +/- 1.93 vs. 35.5 +/- 2 mmHg, p < 0.01) and Fulton's index (0.52 +/- 0.089 vs. 0.67 +/- 0.12, p < 0.001) and less severe right ventricular hypertrophy and distal vessel muscularization. These results suggest that induction of ANP expression in the lung may hold promise in the treatment of pulmonary hypertension.
INSERM U492 and Département de Physiologie, Hôpital Henri Mondor, AP-HP, 94010 Créteil, France.
V
V
Louzier
S
S
Eddahibi
B
B
Raffestin
I
I
Déprez
M
M
Adam
M
M
Levame
M
M
Eloit
S
S
Adnot
D000256:Adenoviridae / Q000235:genetics*; D000818:Animals; D009320:Atrial Natriuretic Factor / Q000096:biosynthesis / Q000235:genetics*; D001358:Avian Sarcoma Viruses / Q000235:genetics; D001835:Body Weight; D001992:Bronchoalveolar Lavage Fluid; D002478:Cells, Cultured; D017077:Culture Media, Conditioned; D006152:Cyclic GMP / Q000378:metabolism; D018076:DNA, Complementary / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D004837:Epinephrine / Q000494:pharmacology; D018014:Gene Transfer Techniques; D006976:Hypertension, Pulmonary / Q000517:prevention & control*; D000860:Hypoxia; D007150:Immunohistochemistry; D008168:Lung / Q000378:metabolism*; D009130:Muscle, Smooth / Q000378:metabolism; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D013997:Time Factors; D014018:Tissue Distribution; D014132:Trachea / Q000378:metabolism; D014162:Transfection; D019076:Transgenes
D017077:Culture Media, Conditioned; D018076:DNA, Complementary; D012333:RNA, Messenger; D009320:Atrial Natriuretic Factor; D006152:Cyclic GMP; D004837:Epinephrine